Delmax Pharmaceuticals Private Limited - Company Profile

It is a chemicals and materials private limited company based in Aurangabad, Maharashtra, India, established in 2019.
2019 Aurangabad, Maharashtra, India Active
Last Updated:
Access Report
About Delmax Pharmaceuticals Private Limited

Delmax Pharmaceuticals Private Limited, a active private limited company, was established on 17 June 2019 in Aurangabad, Maharashtra, India. Engaging in chemical distribution & retail within the manufacturing sector, it holds CIN: U24100MH2019PTC326834. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Dattatray Janardhan Pannabhatti (Director), Bhagyashri Sachin Daskhedkar (Director). Past directors included Renuka Vijay Giri, Bhagyashri Sachin Daskhedkar. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No As-05, Udyog, Indrakamal A Type, Gut No. 70, Beed By Pass Road, Aurangabad, Maharashtra, 431001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2019PTC326834

  • Registration Number

    326834

  • Incorporation Date

    17 June 2019

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 6 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 80.61%
  • Profit Growth **** -24.24%
  • Ebitda **** -139.24%
  • Net Worth 25.01%
  • Total Assets **** 39.23%
Company report

Delmax Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Delmax Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Delmax Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dattatray Janardhan Pannabhatti Director 17 Jun 2019 Current
Bhagyashri Sachin Daskhedkar Director 26 Oct 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Oct 2020 Past
Pramod Abcsdd Additional Director 31 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Delmax Pharmaceuticals.

Delmax Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 80.61% increase. The company also saw a substantial fall in profitability, with a 24.24% decrease in profit. The company's net worth Soared by an impressive increase of 25.01%.

Delmax Pharmaceuticals revenue growth over time
Delmax Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 80.61%
*******
*******
*******
*******
Revenue from Operations
*******
 71.14%
*******
*******
*******
*******
Total Assets
*******
 39.23%
*******
*******
*******
*******
Profit or Loss
*******
 -24.24%
*******
*******
*******
*******
Net Worth
*******
 25.01%
*******
*******
*******
*******
EBITDA
*******
 -139.24%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Delmax Pharmaceuticals?

In 2020, Delmax Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Delmax Pharmaceuticals?

Unlock and access historical data on people associated with Delmax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Delmax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delmax Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Delmax Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Delmax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Delmax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Bhagyashri Sachin Daskhedkar was appointed as a Director was appointed as a Director on 26 Oct 2020 & has been associated with this company since 5 years 3 months . was documented.

  • Director Appointment

    The activity Dattatray Janardhan Pannabhatti was appointed as a Director was appointed as a Director on 17 Jun 2019 & has been associated with this company since 6 years 7 months . was completed.

  • Company Incorporation

    Progress on Delmax Pharmaceuticals Private Limited was registered on 17 Jun 2019 with Roc Mumbai & aged 6 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Delmax Pharmaceuticals Private Limited?

The CIN of Delmax Pharmaceuticals Private Limited is U24100MH2019PTC326834.

Where is Delmax Pharmaceuticals Private Limited headquartered?

Delmax Pharmaceuticals Private Limited is headquartered at Shop No As-05, Udyog, Indrakamal A Type, Gut No. 70, Beed By Pass Road, Aurangabad, Maharashtra, 431001.

When was Delmax Pharmaceuticals Private Limited incorporated?

Delmax Pharmaceuticals Private Limited was incorporated on 17 June 2019.

Who are the current directors of Delmax Pharmaceuticals Private Limited?

The current directors of Delmax Pharmaceuticals Private Limited are

What is the primary industry of Delmax Pharmaceuticals Private Limited?

The primary industry of Delmax Pharmaceuticals Private Limited is Manufacturing.

Is Delmax Pharmaceuticals Private Limited a listed company?

Delmax Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Delmax Pharmaceuticals Private Limited?

The authorized capital of Delmax Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Delmax Pharmaceuticals Private Limited?

The compliance status of Delmax Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available